NEXMED INC

ROBBINSVILLE, NJ How do I update this listing?

Create Email Alert

Nexmed is based out of Robbinsville. Develops and commercializes pharmaceutical and medical therapeutic products based on proprietary delivery systems. The company's focus is on new and patented topical pharmaceutical products based on a penetration enhancement drug delivery technology known as NexACT.
Whalewisdom has at least 183 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-09-14. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

nexmed inc
350 CORPORATE BLVD
ROBBINSVILLE NJ    08691

Business Phone: 6092089688
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-09-14 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,584,950 0 5,584,950
2019-08-30 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,982,750 0 3,982,750
2017-09-27 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 3,691,000 3,691,000 0
2016-10-13 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security 3,653,106 3,653,106 0
2010-03-18 D BIOTECHNOLOGY Debt,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 4,000,000 4,000,000 0
2010-03-10 D BIOTECHNOLOGY Debt,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 2,500,000 2,300,000 200,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
MARK WESTGATE subscription required
    EXECUTIVE OFFICER
BASSAM B. DAMAJ subscription required
    DIRECTOR EXECUTIVE OFFICER
VIVIAN LIU subscription required
    DIRECTOR EXECUTIVE OFFICER
HENRY J. ESBER subscription required
    DIRECTOR EXECUTIVE OFFICER
EDWARD COX subscription required
    EXECUTIVE OFFICER
RICHARD BERMAN subscription required
    DIRECTOR
ROBERTO CREA subscription required
    DIRECTOR
LEONARD A OPPENHEIM subscription required
    DIRECTOR
RUSTY RAY subscription required
    DIRECTOR
KLEANTHIS G. XANTHOPOULOS subscription required
    DIRECTOR
RICHARD W. PASCOE subscription required
    EXECUTIVE OFFICER DIRECTOR
WENDELL WIERENGA subscription required
    DIRECTOR
PAUL V. MAIER subscription required
    DIRECTOR
SANDFORD D. SMITH subscription required
    DIRECTOR
BRIAN DORSEY subscription required
    EXECUTIVE OFFICER
NEIL MORTON subscription required
    EXECUTIVE OFFICER
CATHERINE BOVENIZER subscription required
    EXECUTIVE OFFICER
RAJ MEHRA subscription required
    EXECUTIVE OFFICER DIRECTOR
BRIAN LIAN subscription required
    DIRECTOR
ROBIN L. SMITH subscription required
    DIRECTOR
DANIEL J. O'CONNOR subscription required
    DIRECTOR
JUDITH DUNN subscription required
    DIRECTOR

Elevate your investments